Your browser doesn't support javascript.
loading
Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice.
Okumura, Akinori; Saito, Takeshi; Tobiume, Minoru; Hashimoto, Yuki; Sato, Yuko; Umeyama, Takashi; Nagi, Minoru; Tanabe, Koichi; Unoki-Kubota, Hiroyuki; Kaburagi, Yasushi; Hasegawa, Hideki; Miyazaki, Yoshitsugu; Yamagoe, Satoshi.
Afiliación
  • Okumura A; Department of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Saito T; NARO Western Region Agricultural Research Center, 1-3-1 Senyu-cho, Zentsuji, Kagawa 765-8508, Japan.
  • Tobiume M; Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Hashimoto Y; Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Sato Y; Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Umeyama T; Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Nagi M; Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Tanabe K; Department of Food Science and Human Nutrition, Faculty of Agriculture, Ryukoku University, 1-5 Yokotani, Seta Oe-cho, Otsu, Shiga 520-2194, Japan.
  • Unoki-Kubota H; Department of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Kaburagi Y; Department of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Hasegawa H; Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Miyazaki Y; Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
  • Yamagoe S; Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Biochem Biophys Rep ; 12: 166-171, 2017 Dec.
Article en En | MEDLINE | ID: mdl-29090278
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article